omeprazole has been researched along with Fistula in 3 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Basal, pentagastrin- and histamine-stimulated acid secretion were measured in gastric fistula rats treated with the H+/K(+)-ATPase inhibitor, omeprazole, and the H2-receptor antagonist, ranitidine." | 7.68 | Time course of inhibition of gastric acid secretion by omeprazole and ranitidine in gastric fistula rats. ( Girma, K; Nilsson, G; Romell, B; Seensalu, R, 1990) |
| " One of 21 patients receiving omeprazole developed a fistula in comparison to 6 of 19 patients in the placebo group (p = ." | 5.20 | Effect of perioperative proton pump inhibitors on the incidence of pharyngocutaneous fistula after total laryngectomy: a prospective randomized controlled trial. ( Fagan, JJ; Stephenson, KA, 2015) |
| "Basal, pentagastrin- and histamine-stimulated acid secretion were measured in gastric fistula rats treated with the H+/K(+)-ATPase inhibitor, omeprazole, and the H2-receptor antagonist, ranitidine." | 3.68 | Time course of inhibition of gastric acid secretion by omeprazole and ranitidine in gastric fistula rats. ( Girma, K; Nilsson, G; Romell, B; Seensalu, R, 1990) |
| "Pretreatment with omeprazole to suppress completely gastric acid secretion in the diverted state resulted in a decline in pancreatic secretion similar to that observed after opening the GF." | 1.28 | The importance of gastric secretion in the feedback control of interdigestive and postprandial pancreatic secretion in rats. ( Bilski, J; Konturek, SJ; Krzyzek, E, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stephenson, KA | 1 |
| Fagan, JJ | 1 |
| Konturek, SJ | 1 |
| Krzyzek, E | 1 |
| Bilski, J | 1 |
| Seensalu, R | 1 |
| Girma, K | 1 |
| Romell, B | 1 |
| Nilsson, G | 1 |
1 trial available for omeprazole and Fistula
| Article | Year |
|---|---|
Effect of perioperative proton pump inhibitors on the incidence of pharyngocutaneous fistula after total laryngectomy: a prospective randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Cutaneous Fistula; Double-Blind Method; Female; Fistula; Humans; Lar | 2015 |
2 other studies available for omeprazole and Fistula
| Article | Year |
|---|---|
The importance of gastric secretion in the feedback control of interdigestive and postprandial pancreatic secretion in rats.
Topics: Animals; Benzodiazepinones; Devazepide; Duodenum; Eating; Esters; Fistula; Gabexate; Gastric Juice; | 1991 |
Time course of inhibition of gastric acid secretion by omeprazole and ranitidine in gastric fistula rats.
Topics: Animals; Fistula; Gastric Acid; Gastrins; Histamine; In Vitro Techniques; Male; Omeprazole; Ranitidi | 1990 |